PET Imaging and biodistribution of chemically modified bacteriophage MS2. - Wikidata - awgldk - TriplyDB

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

http://www.wikidata.org/entity/Q39231875

about

Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Virus-Based Nanoparticles as Versatile Nanomachines Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine Multivalent viral capsids with internal cargo for fibrin imaging.Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family Enterobacteriaceae Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice Production and applications of engineered viral capsids.Functionalization of protein-based nanocages for drug delivery applications.Viral chemistry: the chemical functionalization of viral architectures to create new technology.Plant viral and bacteriophage delivery of nucleic acid therapeutics.In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures Virus-templated FRET platform for the rational design of ratiometric fluorescent nanosensors.In Vivo Bacteriophage Biodistribution.Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy.Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery.Quantitative characterization of all single amino acid variants of a viral capsid-based drug delivery vehicle.

P2860

Q27334548-691D0968-B13F-4A0A-8677-9B47D190C9CC Q28068538-75734EF7-9015-48F2-9B55-8BDD7847F95B Q28550482-B606CF49-C8C4-4174-9D4B-2B0DE51E753D Q33800320-C358954D-E3F8-407D-82D8-2CD0588B9328 Q34995724-B5E4C37E-5EF4-43D6-A8C8-D39F26EF1379 Q35963673-22A5597F-FCA5-4FEE-8774-955DFB878AD1 Q35967955-E969FE86-6EBC-40EE-84F3-6D94C0D79604 Q36592213-107FECBF-923B-4D20-815A-0CA330888B79 Q36879532-471B3323-2DBA-4589-B25F-E6CE61E02333 Q37346447-10788FC0-E003-45E0-99D2-B74DC60F2321 Q37531135-2EE4C89A-99E3-4356-A61A-CEFDEC9C506B Q38210894-8DF6D779-B047-438D-8F27-E16DD4139FCE Q38214775-10E574F6-1948-49F1-AA44-2D2729AE4D59 Q38668484-45E248D4-B635-40C0-971F-C8E368995B4D Q39441748-DF498822-CD28-4B47-A8FF-2E7B9527F17B Q41502965-3D93E6CC-B350-4A42-9565-634FF3C61206 Q41716219-D9356220-5362-48BA-8DAA-8ED800AAF2F3 Q43033569-E078009C-0178-4689-A15D-DADAB275DB20 Q47225124-7F9671ED-D1C5-4D23-AB99-EBE1A70010BE Q54290026-1AE9E57E-229D-44B8-A899-B0C54AFEE4EB Q55251922-A21AEAFA-14D7-467B-AA1B-2D45AC8845FC

P2860

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

http://www.wikidata.org/entity/Q39231875

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@en

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@nl

type

label

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@en

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@nl

prefLabel

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@en

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@nl

P1433

Q39231875-AECFCF62-7963-449B-A677-9B7E9DD4E546

P1476

Q39231875-C32D6CCE-EFAA-4406-AA64-6151900C7C6D

P2093

Q39231875-0ED16A17-5D2A-499A-BA35-2C669BC7D8FB

Q39231875-1D5B680D-4C7C-4A73-B534-364848341DE3

Q39231875-39E74BBF-C1A9-4610-B4FE-2BA56B5FAFA4

Q39231875-727A6A6F-DD0F-4C8E-8667-5031BD9BEB5D

Q39231875-976901A0-0A80-4DFB-B7E7-DBFAD5C69758

Q39231875-A7548665-4C36-44B1-9F2B-107C16DD6462

Q39231875-C4F33863-B9DA-430D-B2F0-82328E90C087

P304

Q39231875-5D43DE1B-D516-4EB6-ABF7-B60C630E9E03

P31

Q39231875-DAC61869-D064-49DA-91E8-0AE7738A2F10

P356

Q39231875-AC067AD2-4E95-4D45-80BB-AF0D074C7E1C

P407

Q39231875-93892B14-6EA0-4373-BDD3-70ABA47F9F7B

P433

Q39231875-E2580FB7-F79E-4226-96E9-50C781714B82

P478

Q39231875-9EA4BE57-0115-4D0D-A4A3-29361349056F

P577

Q39231875-95BE204F-5407-45F7-B60C-2B5B2E36B13F

P698

Q39231875-1AFD14CD-905B-4E55-A2EF-F029AC656095

P921

Q39231875-D0608740-12FC-4CCA-94CB-0DD94F7C929D

P356

P1433

Molecular Pharmaceutics

P1476

PET Imaging and biodistribution of chemically modified bacteriophage MS2.

@en

P2093

Christopher R Behrens

http://www.w3.org/2001/XMLSchema#string

Gary J Tong

http://www.w3.org/2001/XMLSchema#string

Ioana L Aanei

http://www.w3.org/2001/XMLSchema#string

James P O'Neil

http://www.w3.org/2001/XMLSchema#string

Matthew B Francis

http://www.w3.org/2001/XMLSchema#string

Michelle E Farkas

http://www.w3.org/2001/XMLSchema#string

Stephanie T Murphy

http://www.w3.org/2001/XMLSchema#string

P304

69-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP3003754

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23214968

http://www.w3.org/2001/XMLSchema#string

P921